Published in Br J Clin Pharmacol on October 01, 1986
Acipimox in combination with low dose cholestyramine for the treatment of type II hyperlipidaemia. Br J Clin Pharmacol (1990) 0.75
Colestipol plus nicotinic acid in treatment of heterozygous familial hypercholesterolaemia. Lancet (1981) 1.14
The interaction between cholestyramine and drugs. Proc Soc Exp Biol Med (1965) 0.99
Reduced triglyceridemia and increased high density lipoprotein cholesterol levels after treatment with acipimox, a new inhibitor of lipolysis. Atherosclerosis (1981) 0.94
Lack of pharmacokinetic interaction of colestipol and fenofibrate in volunteers. Eur J Clin Pharmacol (1980) 0.88
Bioavailability and pharmacokinetics in man of acipimox, a new antilipolytic and hypolipemic agent. J Int Med Res (1981) 0.86
The effect of colestipol hydrochloride on the bioavailability and pharmacokinetics of clofibrate. J Clin Pharmacol (1980) 0.84
Radioimmunoassay of acipimox in human plasma and urine. Pharmacol Res Commun (1984) 0.84
Effects of acipimox, a nicotinic acid derivative, on lipolysis in human adipose tissue and on cholesterol synthesis in human jejunal mucosa. Clin Sci (Lond) (1985) 0.83
High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. Diabetes (2001) 2.02
Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects. Br Med J (Clin Res Ed) (1982) 1.90
Pancreatoduodenectomy with occlusion of the residual stump by Neoprene injection. World J Surg (1989) 1.28
Hypocaloric high-protein diet improves glucose oxidation and spares lean body mass: comparison to hypocaloric high-carbohydrate diet. Metabolism (1994) 1.22
Endocrine responses of type 1 (insulin-dependent) diabetic patients following successful pancreas transplantation. Diabetologia (1983) 1.22
Phase I and endocrine study of exemestane (FCE 24304), a new aromatase inhibitor, in postmenopausal women. Cancer Res (1992) 1.11
Prevalence of depression in patients affected by subclinical hypothyroidism. Panminerva Med (2010) 1.07
Estrogen receptor beta (ERbeta) and inhibition of prostate cancer cell proliferation: studies on the possible mechanism of action in DU145 cells. Mol Cell Endocrinol (2006) 1.06
Gastro-intestinal blood loss during administration of indoprofen, aspirin and ibuprofen. J Int Med Res (1977) 1.05
Aspirin stimulates insulin and glucagon secretion and increases glucose tolerance in normal and diabetic subjects. Diabetes (1978) 1.03
Intranasal glucagon raises blood glucose concentrations in healthy volunteers. Br Med J (Clin Res Ed) (1983) 1.02
Absorption, disposition and preliminary metabolic pathway of 14C-rifabutin in animals and man. J Antimicrob Chemother (1990) 1.00
Sexual differentiation of the brain: role of testosterone and its active metabolites. J Endocrinol Invest (2004) 0.99
Estrogen receptor is expressed in different types of glial cells in culture. J Neurochem (1994) 0.99
Metabolic control of type I (insulin dependent) diabetes after pancreas transplantation. Br Med J (Clin Res Ed) (1985) 0.97
Determination of ethambutol in human plasma and urine by high-performance liquid chromatography with fluorescence detection. J Chromatogr A (1996) 0.97
Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies. Diabetes Obes Metab (2014) 0.96
Effect of weight loss through laparoscopic gastric banding on blood pressure, plasma renin activity and aldosterone levels in morbid obesity. Nutr Metab Cardiovasc Dis (2008) 0.96
The 5alpha-reductase in the central nervous system: expression and modes of control. J Steroid Biochem Mol Biol (1998) 0.95
Patients with insulinoma show insulin resistance in the absence of arterial hypertension. Diabetologia (1992) 0.94
Abnormal sensitivity to glucose of human islets cultured in a high glucose medium: partial reversibility after an additional culture in a normal glucose medium. J Clin Endocrinol Metab (1991) 0.93
Association of obesity and type II diabetes mellitus as a risk factor for gallstones. Dig Dis Sci (2000) 0.93
Effectiveness and safety of laparoscopic adrenalectomy. J Urol (1994) 0.93
Differential localization of the 5 alpha-reductase and the 3 alpha-hydroxysteroid dehydrogenase in neuronal and glial cultures. Endocrinology (1993) 0.91
Stage of change and motivation to healthy diet and habitual physical activity in type 2 diabetes. Acta Diabetol (2014) 0.91
Bariatric surgery in obesity: changes of glucose and lipid metabolism correlate with changes of fat mass. Nutr Metab Cardiovasc Dis (2008) 0.91
Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat Part 2: Effects on reproductive parameters, on sex behavior, on memory retention and on hypothalamic expression of aromatase and 5alpha-reductases in the offspring. Toxicol Appl Pharmacol (2009) 0.91
5 alpha-reductase isozymes in the central nervous system. Steroids (1998) 0.90
Dihydropyridine-sensitive and -insensitive voltage-operated calcium channels participate in the control of glucose-induced insulin release from human pancreatic beta cells. J Endocrinol (1996) 0.90
Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients: a prospective randomized open-label trial. Diabetes Obes Metab (2011) 0.90
Fate of the analgesic and anti-inflammatory drug K 4277 after oral administration to man. Eur J Clin Pharmacol (1973) 0.89
The effect of histamine and H1 and H2 receptors on prolactin and luteinizing hormone release in humans: sex differences and the role of stress. J Clin Endocrinol Metab (1981) 0.89
Hypertriglyceridemia and hyperinsulinemia are potent inducers of endothelin-1 release in humans. Diabetes (1996) 0.89
Transient expression of the 5alpha-reductase type 2 isozyme in the rat brain in late fetal and early postnatal life. Endocrinology (1998) 0.89
Aromatase expression and activity in male and female cultured rat hypothalamic neurons: effect of androgens. Mol Cell Endocrinol (2001) 0.88
Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance. Diabetologia (2011) 0.88
Clinical and hematological aspects of 137Cs: the Goiânia radiation accident. Health Phys (1991) 0.88
Impact of influenza vaccine on response to vaccination with pneumococcal vaccine in HIV patients. AIDS Res Hum Retroviruses (2005) 0.88
Characterization of the chlorpropamide-alcohol-flush in patients with type 1 and type 2 diabetes. Acta Diabetol Lat (1983) 0.87
Pharmacological activity of pregna-1,4-diene-3,20-dione-11 (beta),17(alpha)-21-triol-21-stearoylglycolate. Arzneimittelforschung (1966) 0.87
Endothelial and metabolic characteristics of patients with angina and angiographically normal coronary arteries: comparison with subjects with insulin resistance syndrome and normal controls. J Am Coll Cardiol (1999) 0.87
Epididymitis by Brucella ovis: experimental infection in virgin ram lambs. New Microbiol (1999) 0.86
Bioavailability and pharmacokinetics in man of acipimox, a new antilipolytic and hypolipemic agent. J Int Med Res (1981) 0.86
Medical and related aspects of the Goiânia accident: an overview. Health Phys (1991) 0.86
Analysis of color Doppler signal intensity variation after levovist injection: a new approach to the diagnosis of thyroid nodules. J Ultrasound Med (2001) 0.86
Corrected transposition of the great arteries with isolated aortic coarctation: In utero echocardiographic diagnosis. Pediatr Cardiol (1997) 0.85
Dimorphic expression of testosterone metabolizing enzymes in the hypothalamic area of developing rats. Brain Res Dev Brain Res (2005) 0.84
Leptospirosis in swine--experimental infection with serotype bratislava. Int J Zoonoses (1977) 0.84
Prenatal Aroclor 1254 exposure and brain sexual differentiation: effect on the expression of testosterone metabolizing enzymes and androgen receptors in the hypothalamus of male and female rats. Reprod Toxicol (2006) 0.84
Elevated insulin levels contribute to the reduced growth hormone (GH) response to GH-releasing hormone in obese subjects. Metabolism (1999) 0.84
Radioimmunoassay of acipimox in human plasma and urine. Pharmacol Res Commun (1984) 0.84
Effects of arginine and arginine plus somatostatin infusion on insulin release in diabetic patients submitted to pancreas allotransplantation. Diabete Metab (1988) 0.83
Long-term continuous intraperitoneal insulin treatment in brittle diabetes. Br Med J (Clin Res Ed) (1983) 0.83
Diffusion and practice of ultrasound in emergency medicine departments in Italy. J Ultrasound (2009) 0.83
Metabolic effects of intranasally administered glucagon: comparison with intramuscular and intravenous injection. Acta Diabetol Lat (1986) 0.83
Insulin and intracellular calcium responsiveness to glucagon-like peptide-1 and pituitary adenylate cyclase-activating peptide by dispersed adult porcine islet cells. Transplantation (1999) 0.83
Vesicoureteral reflux in young patients: comparison of voiding color Doppler US with echo enhancement versus voiding cystourethrography for diagnosis or exclusion. Abdom Imaging (2004) 0.83
Metabolism of steroids in the brain: a new insight into the role of 5alpha-reductase and aromatase in brain differentiation and functions. J Steroid Biochem Mol Biol (1996) 0.82
Glucagon improves insulin secretion from pig islets in vitro. J Endocrinol (1995) 0.82
Intranasal calcitonin and plasma calcium concentrations in normal subjects. Br Med J (Clin Res Ed) (1985) 0.82
The fast acetylator phenotype in diabetes mellitus: abnormal prevalence and association with the ABO blood groups. Diabetologia (1984) 0.82
Regulation of endocytic-transcytotic pathways and bile secretion by phosphatidylinositol 3-kinase in rats. Gastroenterology (1997) 0.82
Metabolism and kinetics of the hypoglycemic agent glipizide in man--comparison with glibenclamide. J Clin Pharmacol New Drugs (1973) 0.82
Identification of type 1 5alpha-reductase in myelin membranes of male and female rat brain. Mol Cell Endocrinol (1997) 0.82
Acute renal failure after intragastric balloon in morbidly-obese metformin-treated diabetic patients. Report of two cases. Nutr Metab Cardiovasc Dis (2011) 0.81
Testosterone and progesterone metabolism in the central nervous system: cellular localization and mechanism of control of the enzymes involved. Cell Mol Neurobiol (1996) 0.81
Acute pharmacologic blockade of lipolysis normalizes nocturnal growth hormone levels and pulsatility in obese subjects. Metabolism (1994) 0.81
Efficacy and safety of acarbose in the treatment of Type 1 diabetes mellitus: a placebo-controlled, double-blind, multicentre study. Diabet Med (1999) 0.81
The hypotonic effect of intranasal and intravenous glucagon in gastrointestinal radiology. Abdom Imaging (1995) 0.81
Alterations in nitric oxide/cyclic-GMP pathway in nondiabetic siblings of patients with type 2 diabetes. J Clin Endocrinol Metab (2000) 0.81
5 alpha-reductase activity in isolated and cultured neuronal and glial cells of the rat. Brain Res (1990) 0.81
Pathogenesis of diabetic neuropathy--do hyperglycemia and aldose reductase inhibitors affect neuroactive steroid formation in the rat sciatic nerves? Exp Clin Endocrinol Diabetes (2002) 0.80
Intercellular Ca2+ waves sustain coordinate insulin secretion in pig islets of Langerhans. FEBS Lett (1996) 0.80
Determination of 3'-deamino-3'-[2(S)-methoxy-4-morpholinyl]doxorubicin, a new morpholinyl anthracycline, in plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr (1992) 0.80
Laparoscopic bilateral adrenalectomy for persistent Cushing's disease after transsphenoidal surgery. Surgery (1998) 0.80
Evidence for an inhibitory effect of physiological levels of insulin on the growth hormone (GH) response to GH-releasing hormone in healthy subjects. J Clin Endocrinol Metab (1997) 0.80
Progesterone 5-alpha-reduction in neuronal and in different types of glial cell cultures: type 1 and 2 astrocytes and oligodendrocytes. Brain Res (1994) 0.80
Determination of exemestane, a new aromatase inhibitor, in plasma by high-performance liquid chromatography with ultraviolet detection. J Chromatogr (1993) 0.80
Biochemical and immunochemical studies on the GABAergic system in the rat fallopian tube and ovary. J Neurochem (1984) 0.80
Usefulness of chemical-shift MRI in discriminating increased liver echogenicity in glycogenosis. Dig Liver Dis (2007) 0.80
Forearm insulin- and non-insulin-mediated glucose uptake and muscle metabolism in man: role of free fatty acids and blood glucose levels. Metabolism (1991) 0.80
Nicotinamide improves insulin secretion and metabolic control in lean type 2 diabetic patients with secondary failure to sulphonylureas. Acta Diabetol (1998) 0.80
Relationship between endothelin-1 concentration and metabolic alterations typical of the insulin resistance syndrome. Metabolism (2000) 0.80
Experimental infection of dogs with Borrelia burgdorferi. Res Vet Sci (1994) 0.80
Experimental infection of sheep with Chlamydia psittaci. Br Vet J (1987) 0.80
Prevalence of erectile dysfunction in thyroid disorders: comparison with control subjects and with obese and diabetic patients. Int J Impot Res (2006) 0.80
Comparison between two methods for periodontal risk assessment. Minerva Stomatol (2009) 0.80
[Is echography an adequate method for assessing the thickness of intra-abdominal fat? A comparison with computed tomography]. Radiol Med (1997) 0.80
Impairment of growth hormone and insulin secretion in hyperthyroidism. Eur J Clin Invest (1974) 0.80
Fecal cholesterol excretion studies in type II hypercholesterolemic patients treated with the soybean protein diet. Atherosclerosis (1982) 0.79
Human islets chronically exposed in vitro to different stimuli become unresponsive to the same stimuli given acutely: evidence supporting specific desensitization rather than beta-cell exhaustion. J Clin Endocrinol Metab (1992) 0.79
Ratio of the R and S enantiomers of salsolinol in food and human urine. J Neural Transm (1989) 0.79
A study of the effects of rifabutin on isoniazid pharmacokinetics and metabolism in healthy volunteers. Drug Metabol Drug Interact (1992) 0.79
Evaluation of tests employed in serological diagnosis of brucellosis caused by Brucella ovis. New Microbiol (2000) 0.79
Effects of endothelin-1 and nitric oxide on glucokinase activity in isolated rat hepatocytes. Metabolism (2000) 0.79
Effect of L-dopa administration on growth hormone secretion in normal subjects and Parkinsonian patients. J Endocrinol (1972) 0.79
Benserazide, a stimulator of prolactin release: a new test in the diagnosis of pituitary prolactin-secreting tumours. Acta Endocrinol (Copenh) (1981) 0.79
Testosterone metabolism in peripheral nerves: presence of the 5 alpha-reductase-3 alpha-hydroxysteroid-dehydrogenase enzymatic system in the sciatic nerve of adult and aged rats. J Steroid Biochem (1990) 0.79